ECHS1

Chr 10AR

enoyl-CoA hydratase, short chain 1

Also known as: ECHS1D, SCEH, mECH, mECH1

The protein encoded by this gene functions in the second step of the mitochondrial fatty acid beta-oxidation pathway. It catalyzes the hydration of 2-trans-enoyl-coenzyme A (CoA) intermediates to L-3-hydroxyacyl-CoAs. The gene product is a member of the hydratase/isomerase superfamily. It localizes to the mitochondrial matrix. Transcript variants utilizing alternative transcription initiation sites have been described in the literature. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.961 OMIM phenotype
Clinical SummaryECHS1
🧬
Gene-Disease Validity (ClinGen)
Leigh syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
65 unique Pathogenic / Likely Pathogenic· 111 VUS of 410 total submissions
📖
GeneReview available — ECHS1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.96LOEUF
pLI 0.001
Z-score 1.69
OE 0.51 (0.290.96)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.86Z-score
OE missense 0.81 (0.700.94)
131 obs / 161.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.51 (0.290.96)
00.351.4
Missense OE?0.81 (0.700.94)
00.61.4
Synonymous OE?1.07
01.21.6
LoF obs/exp: 7 / 13.8Missense obs/exp: 131 / 161.9Syn Z: -0.42
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveECHS1-related mitochondrial short-chain enoyl-CoA hydratase 1 deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.78top 25%
GOF
0.6247th %ile
LOF
0.2776th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

410 submitted variants in ClinVar

Classification Summary

Pathogenic27
Likely Pathogenic38
VUS111
Likely Benign153
Benign41
Conflicting29
27
Pathogenic
38
Likely Pathogenic
111
VUS
153
Likely Benign
41
Benign
29
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
13
4
0
27
Likely Pathogenic
7
29
1
1
38
VUS
3
93
13
2
111
Likely Benign
0
3
76
74
153
Benign
0
2
36
3
41
Conflicting
29
Total2014013080399

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

97 pathogenic / likely-pathogenic (of 119) ClinVar copy-number / structural variants overlap ECHS1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ECHS1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →